Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatectomy | 2 | 2020 | 58 | 1.380 |
Why?
|
| Pancreatic Neoplasms | 4 | 2022 | 332 | 1.380 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 334 | 1.070 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 581 | 1.050 |
Why?
|
| Goals | 1 | 2022 | 65 | 0.810 |
Why?
|
| Travel | 1 | 2020 | 38 | 0.720 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 475 | 0.720 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2019 | 3 | 0.680 |
Why?
|
| Pancreatectomy | 4 | 2022 | 129 | 0.660 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 163 | 0.630 |
Why?
|
| Retrospective Studies | 12 | 2022 | 7277 | 0.390 |
Why?
|
| Gastroparesis | 2 | 2020 | 7 | 0.370 |
Why?
|
| Hospitals, Low-Volume | 2 | 2020 | 12 | 0.370 |
Why?
|
| Hospitals, High-Volume | 2 | 2020 | 18 | 0.370 |
Why?
|
| Electric Stimulation Therapy | 2 | 2020 | 147 | 0.330 |
Why?
|
| Pancreatitis, Chronic | 2 | 2021 | 168 | 0.300 |
Why?
|
| Postoperative Complications | 6 | 2022 | 1615 | 0.290 |
Why?
|
| Pancreatic Diseases | 2 | 2017 | 66 | 0.270 |
Why?
|
| Survival Rate | 4 | 2020 | 1056 | 0.230 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2022 | 34 | 0.210 |
Why?
|
| Male | 13 | 2022 | 37321 | 0.200 |
Why?
|
| Length of Stay | 2 | 2022 | 780 | 0.190 |
Why?
|
| Humans | 16 | 2022 | 68618 | 0.190 |
Why?
|
| Academies and Institutes | 1 | 2020 | 31 | 0.190 |
Why?
|
| Bile Ducts | 1 | 2021 | 59 | 0.180 |
Why?
|
| Treatment Outcome | 8 | 2020 | 7029 | 0.180 |
Why?
|
| Mitosis | 1 | 2020 | 76 | 0.180 |
Why?
|
| Pancreatitis | 1 | 2022 | 279 | 0.170 |
Why?
|
| Surgeons | 1 | 2020 | 68 | 0.170 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 274 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 96 | 0.170 |
Why?
|
| Sphincterotomy, Transduodenal | 1 | 2019 | 24 | 0.170 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 18 | 0.160 |
Why?
|
| Aged | 6 | 2020 | 14862 | 0.160 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 58 | 0.160 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 30 | 0.160 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 792 | 0.160 |
Why?
|
| Pancreatic Ducts | 1 | 2019 | 76 | 0.160 |
Why?
|
| Sphincter of Oddi Dysfunction | 1 | 2019 | 48 | 0.160 |
Why?
|
| Gastric Bypass | 1 | 2019 | 83 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2020 | 622 | 0.150 |
Why?
|
| Female | 11 | 2022 | 38074 | 0.150 |
Why?
|
| Patient Selection | 2 | 2019 | 592 | 0.150 |
Why?
|
| Skin | 1 | 2020 | 451 | 0.140 |
Why?
|
| Colonic Diseases | 1 | 2017 | 36 | 0.140 |
Why?
|
| Colectomy | 1 | 2017 | 64 | 0.140 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2017 | 101 | 0.140 |
Why?
|
| Melanoma | 1 | 2020 | 335 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 375 | 0.130 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2019 | 348 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2016 | 172 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 100 | 0.120 |
Why?
|
| Middle Aged | 8 | 2020 | 21147 | 0.120 |
Why?
|
| Mutation | 1 | 2019 | 1213 | 0.110 |
Why?
|
| Osteoradionecrosis | 1 | 2011 | 7 | 0.100 |
Why?
|
| Mandibular Diseases | 1 | 2011 | 28 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2011 | 57 | 0.100 |
Why?
|
| Free Tissue Flaps | 1 | 2011 | 67 | 0.090 |
Why?
|
| Gastric Emptying | 2 | 2020 | 24 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2010 | 82 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 384 | 0.080 |
Why?
|
| Surgical Flaps | 1 | 2010 | 120 | 0.080 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2010 | 94 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 629 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2010 | 206 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 446 | 0.070 |
Why?
|
| Pancreatic Fistula | 1 | 2022 | 23 | 0.050 |
Why?
|
| Adult | 5 | 2020 | 21403 | 0.050 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2021 | 4 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 2093 | 0.050 |
Why?
|
| Injections | 1 | 2021 | 119 | 0.050 |
Why?
|
| Solutions | 1 | 2021 | 115 | 0.050 |
Why?
|
| Sentinel Lymph Node | 1 | 2020 | 4 | 0.050 |
Why?
|
| Nausea | 1 | 2020 | 47 | 0.050 |
Why?
|
| Vomiting | 1 | 2020 | 56 | 0.050 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2020 | 53 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 153 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2020 | 218 | 0.040 |
Why?
|
| Risk Factors | 2 | 2022 | 5731 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3259 | 0.040 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2019 | 18 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 536 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 2019 | 35 | 0.040 |
Why?
|
| Sphincter of Oddi | 1 | 2019 | 51 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 174 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 5717 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2021 | 470 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 109 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2019 | 159 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 145 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2019 | 384 | 0.040 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 172 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4848 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2016 | 95 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 786 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 117 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 2791 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2007 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2550 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1420 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 506 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 20 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2011 | 45 | 0.020 |
Why?
|
| Bone Transplantation | 1 | 2011 | 43 | 0.020 |
Why?
|
| Mandible | 1 | 2011 | 53 | 0.020 |
Why?
|
| Bone Plates | 1 | 2011 | 49 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 46 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 3705 | 0.020 |
Why?
|
| Device Removal | 1 | 2011 | 100 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 4655 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 168 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2223 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 742 | 0.020 |
Why?
|
| Wound Healing | 1 | 2011 | 260 | 0.020 |
Why?
|
| Quality of Life | 1 | 2017 | 1515 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 349 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2324 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 8912 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 951 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 561 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 2358 | 0.020 |
Why?
|
| Animals | 1 | 2021 | 20881 | 0.010 |
Why?
|